NA
COLL icon

NewEdge Advisors’s Collegium Pharmaceutical COLL Stock Holding History

NewEdge Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$894K Buy
27,029
+14,348
+113% +$607K ﹤0.01% 1567
2025
Q4 		$587K Sell
12,681
-6,695
-35% -$280K ﹤0.01% 1857
2025
Q3 		$678K Buy
19,376
+16,329
+536% +$568K ﹤0.01% 1639
2025
Q2 		$90.1K Buy
3,047
+2,294
+305% +$65.4K ﹤0.01% 2455
2025
Q1 		$22.5K Buy
+753
New +$23K ﹤0.01% 2825
2023
Q3 		– Sell
-136
Closed -$2.92K – 3500
2023
Q2 		$2.92K Sell
136
-81
-37% -$1.84K ﹤0.01% 2980
2023
Q1 		$5.21K Sell
217
-1,621
-88% -$43K ﹤0.01% 2758
2022
Q4 		$37.6K Buy
+1,838
New +$37.1K ﹤0.01% 1843

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return